The 18th Congress of the Japanese Society for Regenerative Medicine was held from March 21e23, 2019, at Kobe International Conference Center (Hyogo Prefecture) with 3,576 participants. The theme of this congress was "Message from the Birthplace of Regenerative Medicine" with expectation of disseminating the message of 'saving patients with regenerative medicine' for the future. With this theme, this congress aimed to provide opportunity for accelerating the development of this field through exchanging information among people from all participants (including individuals from academia, various industries, and regulatory authorities). Numerous topics were covered in the one presidential lecture, one congress president's lecture, one keynote lecture, one invited lecture, three special lectures, three educational lectures, four special programs including two joint symposia with oversea society (13 topics), one award lecture program (four lectures), symposia (46 sessions, 460 topics), oral presentations (38 sessions, 219 topics), poster presentations (77 sessions, 417 topics), 32 co-organized seminars (39 talks), and the stateof-the-art technology showcase (178 organizations). Additionally, two sessions for junior high school and high school students (basic course and advanced course) were held during the conference.
Objectives
The theme of the Congress was "Message from the Birthplace of Regenerative Medicine." This theme was derived from the story of the "White Hare of Inaba" recorded in "Kojiki" (The Records of Ancient Matters), in which Okuninushi-no-mikoto (the Great Land Master) treated and regenerated the injured skin of a white rabbit. Our hope of disseminating the message of "saving patients with regenerative medicine" for the future was conveyed in this theme. With this theme, this congress aimed to provide opportunity for accelerating the development of regenerative medicine through exchanging information among all participants through the various programs which were featured on mainly three topics.
As the first topic, a program by individual organs or a multidisciplinary program, focusing on "treatment," was planned in line with the theme "Message from the Birthplace of Regenerative Medicine." The second topic was planned regarding the efforts toward the practical use of regenerative medicine in the academic, industrial, administrative, and economic fields to enhance the cooperation among the fields for achieving the best practical use of regenerative medicine. As the third topic, to promote partnerships between the Japanese and overseas regenerative medicine fields, an international session was planned and simultaneous interpretation at the main hall during the congress was provided.
Participants
There were 3,576 participants in total. The congress had 3,429 participants in the scientific sessions. The breakdown of the participants are as follows: 1,564 general members, 264 graduate student members, 1,408 non-members (1,196 general, 117 graduate students, and 95 university students), 122 corporate members (109 regular members and 13 associate members), and 71 invitees. In addition, 147 junior-high-school, high-school, and teachers joined the sessions for junior-high-school and high school students (basic course, 80 students; advanced course, 37 students). In addition to participants with backgrounds in basic medicine, dentistry, clinical medicine, physicians, and dentists, participants also comprised industrial researchers and those with administrative positions.
Lectures
The conference provided one presidential lecture, one congress president's lecture, one keynote lecture, one invited lecture, three special lectures, and three educational lectures. As the president of the Japanese Society for Regenerative Medicine (JSRM), Dr. Yoshiki Sawa (Osaka University) delivered the presidential lecture entitled 'Activities of JSRM in 2018' (chairperson: Dr. Goshi Shiota, Tottori University). Dr. Sawa introduced that the JSRM stated the slogan of 'Orchestrating wisdom to innovate, universalize for the happiness and future of all the human beings' in 2019, and he mentioned an importance of universalizing regenerative medicine. To make it realized, Dr. Sawa also introduced the efforts and the outcomes of the on-going project entitled 'Formulation of regenerative medicine national consortium which renders nation-wide assistance to clinical researches' commissioned by the Japan Academy for Medical Research and Development (AMED). From the start of this project, construction of platform for universalizing regenerative medicine has been proceeded to facilitate the practical application of regenerative medicine based on the following three basic programs: (1) support for regenerative medicine clinical researches, (2) human resource developments for regenerative medicine, and (3) the management and operation of regenerative medicine clinical research data systems.
The Congress Chair Dr. Goshi Shiota delivered Congress President Lecture on the topic of 'Messages from the birthplace of regenerative medicine' (chairperson: Dr. Yoshiki Sawa). In the former part of the lecture, Dr. Shiota introduced the overview of this congress and the progress in regenerative medicine therapy in line with the congress theme 'Message from the Birthplace of Regenerative Medicine.' Dr. Shiota also presented 'Cell sheets therapy for liver disease' in the latter part of the lecture. The cell sheets are developed by treating bone marrow-derived mesenchymal stem cells with their original Wnt/b-catenin signaling inhibitor, manufactured on thermo-responsive polymer-coated culture dish. The cell sheets prepared in the above way potently reverse the established liver fibrosis by transplantation on the surface of the liver. Dr. Shiota finally concluded that cell sheets therapy would be a promising and powerful therapeutic option for severe liver disease.
The keynote lecture was delivered by Dr. Tsutomu Tomioka, a member of the House of Representatives (chairperson: Dr. Yoshiki Sawa). Dr. Tomioka's lecture entitled 'What policy can promote regenerative medicine: a proposal from the members of the National Diet' summarized the agendas of the members of the National Diet who promote regenerative medicine as follows: establishment of a system for continuous generation of products from regenerative medicine, improvement in the techniques for cell preparation, acceleration of the approval examination, and the health economical approach to establish a basic and comprehensive system accelerating the research in regenerative medicine.
Three special lectures were performed by Dr. Kunio Ito (Hitotsubashi University), Dr. Shinya Yamanaka (Kyoto Univeristy), and Dr. Atsushi Miyajima (The University of Tokyo), respectively. Dr. Kunio Ito delivered a lecture entitled 'Dialogue with investors and institutional reform for the growth of bio-ventures' (chairperson: Dr. Goshi Shiota). His lecture basically depended on "Ito Report 2.0, a report of the study group for encouraging dialogue between biotech venture businesses and investors, biomedical edition" published in April 2018. He proposed a new system and criteria to put money to bio-ventures from the view point of special nature of biotechnology businesses.
Dr. Shinya Yamanaka (Kyoto University) delivered a lecture entitled 'Recent progress in iPS cell research and application' (chairperson: Dr. Goshi Shiota). To promote regenerative medicine using iPS cells (iPSCs), it requires to develop iPSC bank which covers many Japanese people with different types of human leukocyte antigen (HLA). The project is ongoing in Center for iPS Cell Research and Application (CiRA). Since it takes a lot of time and money to build up the iPSC bank which covers many Japanese people, Dr. Yamanaka introduced new trials to establish HLA homozygous iPSCs, which are expected to resolve these issues.
Dr. Atsushi Miyajima (The University of Tokyo) delivered a lecture entitled 'Cellular basis of liver regeneration and construction of liver tissue using iPSCs' (chairperson: Dr. Goshi Shiota). Dr. Miyajima summarized the mechanisms of liver regeneration, especially focused on liver progenitor cells (LPC)-driven regeneration. In addition, he presented the development of iPSCs-derived liver progenitor cells and hepatic non-parenchymal cells (e.g., hepatic stellate cells).
The invited lecture was delivered by Dr. Gene P. Siegal (University of Alabama at Birmingham, USA). The chairperson was Dr. Akihiro Umezawa (National Center for Child Health and Development). Dr. Siegal's lecture, entitled 'Five secrets from a journal editorial office' presented five advices based on his experience as author, reviewer, and editor.
Three educational lectures included the following. Dr. Junya Toguchida (Kyoto University) delivered a lecture entitled 'Application of disease-specific iPSCs for disease modeling and drug development' (chairperson: Dr. Tatsutoshi Nakahata, Kyoto University). Dr. Toguchida and his colleagues established diseasespecific iPSCs with Fibrodysplasia Ossificans Progressiva (FOP). He found that activin A is a therapeutic target for FOP, and that sirolimus is a candidate therapeutic agent for FOP. Dr. Toguchida is advancing clinical trials for FOP patients.
Dr. Hideyuki Okano (Keio University) delivered a lecture entitled 'iPSCs-based regenerative medicine and drug development' (chairperson: Dr. Tsuyoshi Takato, JR Tokyo General Hospital). He summarized the development of regenerative medicine for spinal cord injury using iPSC-derived neural progenitor cells (iPS-NPCs) in the former part of the lecture, and presented drug discovery research using iPSCs in the latter part of the lecture.
Dr. Tatsuya Shimizu (Tokyo Women's Medical University) delivered a lecture entitled 'Recent advances and future views of tissue engineering' (chairperson: Dr. Masayuki Yamato, Tokyo Women's Medical University). His lecture overviewed the tissue engineering from view of basic to future application. 3D tissue can already be produced by bioprinting technology using 3D printers or cell sheets technology, however, it is necessary to provide vascular network to improve tissue function.
Four 
The symposia
The Congress offered 46 concurrent symposia (233 talks in total). The session titles and organizers are listed in Table 1 . To promote partnerships between the Japanese and overseas regenerative medicine participants, an international session was held entitled 'International Symposium:Top story of regenerative medicine and stem cell research' as novel attempt at the congress. Besides this, several sessions were based on therapy for focusing on each organ in line with the theme 'Message from the birthplace of regenerative medicine.' Moreover, multidisciplinary sessions such as framework for promotion of regenerative medicine, national consortium, regenerative medicine and rehabilitation, efforts aiming the industrialization of regenerative medicine of industries, government and academic organizations, study on tumorigenicity assessment of cell therapy products, recent progress in RNA technologies and stem cell biology, etc. covered a broad spectrum of topics related to regenerative medicine.
The Technoauction between academic and industrial fields was held in two parts. In the former part, six speakers from academic field presented (chairpersons: Dr. Ken-ichiro Hata, Japan Tissue Engineering Co., Ltd. and Dr. Yasuhiko Tabata, Kyoto University). In the latter part, six persons also presented (chairpersons: Dr. Kenichiro and Dr. Atsuhiro Saito, Osaka University).
The regular presentations (oral presentations and poster presentations)
The regular presentations included 219 oral presentations and 417 poster presentations. The regular presentations were peer reviewed by the peer review committee and selected by the organizers, based on reviewer's evaluation of the submitted abstracts. The oral presentations were classified into 38 sessions, each of which had five to seven presentations, depending on their topics as follows: pluripotent stem cells, somatic stem cell, tissue engineering, nervous system, regeneration of locomotorium, osteoblast differentiation, visual sense/auditory sense/olfactory sense, oral cavity and its surrounding tissues, respiratory system, heart, blood vessel, liver, pancreas, digestive system, urinary system, skin/ appendicular, engineering technology, basic technology and others, preservation technology/transportation technology, and others. Two young Japanese investigators and two young Korean investigators from KSSCR were selected and were presented a chance to talk their papers in Young investigators session. The poster presentations were delivered in 77 sessions concerning the following topics: pluripotent stem cells, disease model/drug discovery, differentiation, culture, preservation, quality evaluation, saftey test/quality evaluation, exosomes, somatic stem cells, cancer stem cells, tissue engineering, biomaterials, nervous system, locomotorium, regeneration of locomotorium, visual sense/auditory sense/olfactory sense, oral cavity, respiratory system, heart/Blood vessel, blood/immune system, liver, pancreas, digestive system, urinary system, skin/appendicular, culture process/preservation technology/transportation technology, safety tests/quality evaluations, cell processing facility, regulatory science. Among poster presentations, 28 young investigators whose abstracts are excellent briefly spoke their papers in Poster teasers sessions at the main hall.
Co-organized seminars
The Congress provided 30 co-organized luncheon seminars and two morning seminar (39 talks in total). The seminars also covered a broad spectrum of topics related to regenerative medicine and its peripheral technology. In addition, there were some unique coorganized seminars including the efforts of KOBE Biomedical Innovation Center 20th Anniversary and the presentation of editorial board members of JSRM official English journal 'Regenerative Therapy.'
Sessions for junior high school and high school students
Two courses, basic and advanced, were held. In the basic course, 80 students toured the state of the art technology showcase to learn about the latest technology. Seven groups made poster presentations obtained in their biological research activities at schools. Dr. Yuichi Tei (The University of Tokyo) and Dr. Eiji Kobayashi (Keio University) delivered a special lecture to the students. In the advanced course, students gave oral presentations on the given theme concerned "stem cells/regenerative medicine research þ xxxx ¼ realization of yyyy.' The students were allowed to create anything 'yyyy' that their group wants to realize for a new idea in the future by adding 'xxxx' to the current stem cells and/or regenerative medicine research. The oral presentations were evaluated by executive board members of the JSRM. In the essay contest, their essays on the theme "After reading white hare of Inaba recorded in Kojiki, describe your thoughts on the future of medical care" were evaluated. The students listened to the presidential lecture by Dr. Sawa, the Congress presidential lecture by Dr. Shiota, and the special lecture by Dr. Yamanaka. The Sessions for junior high school and high school students was planned and executed by Dr. Kenji Ishihara (Ibaraki University), Dr. Masahiro Kawakami (Nara Institute of Science and Technology), and Dr. Kazufumi Suzuki (Ibaraki University). These sessions were supported by the Japan Science and Technology Agency, Hyogo Prefectural Board Education, Kobe City Board of Education, Tottori Prefectural Board of Education, Ibaraki Prefectural Board of Education, and Gamagori City.
9. The state-of-the-art technology showcase
One hundred and seventy-eight organizations showcased their available products and technologies related to regenerative medicine at the State-of-the-Art Technology Showcase. They include laboratory equipment, chemicals, reagents, and systems used in clinical settings and research for regenerative medicine.
The public program
The public programs were held on March 24th, 2019 at Kobe International Conference Center (Hyogo Prefecture) and on April 14th at Yonago Convention Center (Tottori Prefecture 11. The organizers, the executive committee, and the peer review committee
